Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of acute adverse effects in 45 patients treated with bevacizumab in combination with neoadjuvant chemoradiotherapy
| Toxicity (NCI-CTC Version 3.0) | No. of patients | |||
|---|---|---|---|---|
| Grade 1 | Grade 2 | Grade 3 | Grade 4 | |
| Hematological | ||||
| Leukopenia | 11 | 8 | 3 | 1 |
| Neutropenia | 16 | 6 | 1 | 1 |
| Thrombocytopenia | 1 | 0 | 0 | 0 |
| Non-hematological | ||||
| Diarrhea | 10 | 2 | 2 | 0 |
| Nausea or vomiting | 17 | 2 | 0 | 0 |
| Hand-foot syndrome | 3 | 0 | 0 | 0 |
| Radiation dermatitis | 4 | 0 | 1 | 0 |
| Neuropathy | 15 | 0 | 0 | 0 |
| Proteinuria | 2 | 0 | 0 | 0 |
